So much can happen on a daily and weekly basis in the biopharma sphere, and it’s easy to forget what the big stories were a few weeks ago, let... read more
Sun, 08/18/19 - 04:20 pm
admin
“Dr. Dave either you are a no-talent doc-in-the-box hack with time between "patients" or you are sitting out your time on suspension for writing too many scripts for "hillbilly heroin". There is a... read more
Monopar Therapeutics filed the paperwork for its IPO on 8/15/2019. The company will raise up to $40 Million. Monopar is a clinical stage biopharmaceutical company. The company will trade on NASDAQ... read more
Smile Direct Club filed the paperwork for its IPO on 8/16/19. The company provides clear orthodontic aligners direct to consumers. They compete with market leader Invisalign. The company will... read more
Silk Road Medical recently filed the paperwork for a $159 Million public offering. The announcement comes not long after Silk Road raised $109 with its IPO in April of 2019.
The Sunnyvale... read more
Vida Ventures, which describes itself as a next-generation life sciences venture firm announced on 8/1/19 the closing of Vida Ventures II, LLC (“Vida II”),... read more
Vapotherm recently filed the paperwork for a new $57 Million offering. The company's HI-VNI technology provides maskless high velocity nasal insufflation for patients in respiratory distress or... read more
In a previous article (found here), we discussed the findings of a 2016 study that... read more
On July 11, 2019, the U.S. Department of Justice announced that Reckitt Benckiser Group PLC agreed to pay $1.4 billion to resolve possible criminal and civil liability related to allegations... read more
Life science investment firm, Medicxi, announced on 7/19/19 that it has closed its Medicxi III fund. This brings the total amount raised by Medicxi in the last three years to over $1 billion. The... read more
4D Pharma Commences Ph 1/II Asthma Trial
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces an update on its... read more
Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, announced on 7/16/19... read more
Life science focused Vida Ventures is advancing on its goal of raising $600 million for its second VC fund. According to a recent... read more
Clinical stage biopharma, Xynomic Pharma, filed the paperwork for a new $65 Million offering. The company is developing small molecule treatments for several different cancer types. It trades on... read more
Clinical stage biopharma RAPT Therapeutics filed the paperwork for its IPO on 6/5/19. The company is focused on developing therapies targeting immune drivers of cancer and inflammation. They... read more
Oxford Vacmedix UK Limited (OVM), the UK-based biopharma company focused on the development of cancer vaccines, announced today the award of an Innovate UK grant to CHAIN Biotech Ltd (CHAIN) and... read more
While the pharmaceutical industry is a fast-growing sector of healthcare, different types of fraud are committed and reported to the government.... read more
Livongo Health, a company focused on aiding those with chronic conditions, filed for a $100 million IPO on 6/28/19. The initial filing does not specify the number of shares to be offered. The... read more